Basal Cell and Squamous Cell Carcinoma

Understanding basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) is essential for any medical student or future clinician. These are the most common human cancers overall, and their diagnosis, management, and underlying biology are high-yield topics for the MCAT and medical school curricula. Mastering their distinctions—from clinical appearance to metastatic potential—equips you with foundational knowledge for both exam success and future patient care, emphasizing the critical role of sun protection and early detection.

Epidemiology and Shared Risk Factors

Both BCC and SCC are classified as non-melanoma skin cancers and share a primary causative agent: cumulative ultraviolet (UV) radiation exposure. The risk increases with lifetime sun exposure, history of sunburns, and residence in sunny climates. UVB radiation is particularly culpable, causing direct DNA damage in skin cells that can lead to mutations in tumor suppressor genes like TP53. Beyond UV exposure, immunosuppression is a major risk factor. Patients who have undergone organ transplantation or who have conditions like chronic lymphocytic leukemia have a significantly elevated risk, especially for SCC, due to diminished immune surveillance against dysplastic cells. Other shared risk factors include fair skin (Fitzpatrick types I-III), older age, male gender, and exposure to ionizing radiation or arsenic.

Basal Cell Carcinoma: Pathogenesis and Clinical Presentation

Basal cell carcinoma originates from the basal keratinocytes of the epidermis and the outer root sheath of hair follicles. Its pathogenesis is heavily linked to mutations in the Patched (PTCH1) tumor suppressor gene, a key regulator of the Sonic Hedgehog (SHH) signaling pathway. Unchecked SHH signaling drives uncontrolled cell proliferation.

Clinically, BCC most often presents on sun-exposed areas, most commonly the head and neck. The classic presentation is a pearly papule with overlying telangiectasias (fine, dilated blood vessels visible on the surface) and rolled borders. It may ulcerate centrally, forming a "rodent ulcer." While it is locally invasive and can cause significant tissue destruction if neglected, BCC rarely metastasizes, with rates estimated at less than 0.1%. This biological behavior is a critical distinction from other malignancies. Other clinical subtypes include nodular (the most common), superficial (appearing as a scaly, red patch), morpheaform (scar-like and infiltrative), and pigmented (which can mimic melanoma).

Squamous Cell Carcinoma: Pathogenesis and Clinical Presentation

Squamous cell carcinoma arises from the keratinocytes of the epidermal spinous layer. Its development often follows a progression from actinic keratosis (a precancerous scaly lesion) to carcinoma in situ (Bowen's disease), and finally to invasive SCC. Key molecular events involve TP53 mutations and dysregulation of cell cycle pathways.

SCC typically appears on sun-exposed sites like the face, ears, lips, and dorsa of hands. It commonly presents as a firm, scaly plaque or an ulcerated nodule with a hard, hyperkeratotic surface. The edges are often elevated and indurated. Unlike BCC, SCC carries a potential for metastasis, which can occur via lymphatic or hematogenous spread. The risk of metastasis varies (generally 2-5% but higher in certain locations like the lip or ear, and in immunosuppressed patients). Factors increasing metastatic risk include greater tumor depth (>2 mm invasion), perineural invasion, location on high-risk sites, poor differentiation, and recurrence after treatment.

Histopathology and Diagnosis

While clinical diagnosis is common, biopsy with histopathological examination is the gold standard for confirmation and guides management. For BCC, histology shows nests of basaloid cells with peripheral palisading (cells aligned in a row) and retraction artifacts between the tumor nests and the surrounding stroma. SCC is characterized by invasive cords and nests of atypical keratinocytes extending into the dermis, often with keratin pearl formation and intercellular bridges (desmosomes).

For the MCAT, connect this histology to cell biology: palisading relates to cell adhesion and polarity, while keratin pearls are a visual marker of abnormal differentiation (keratinization) within the tumor. Diagnosis also involves assessing the tumor's margins and depth of invasion, which are prognostic indicators, especially for SCC.

Management Principles and MCAT Integration

Management is tailored to the tumor type, size, location, and patient factors. The primary goal for both is complete surgical excision. Mohs micrographic surgery is a tissue-sparing technique favored for high-risk locations (e.g., face), recurrent tumors, or those with aggressive histologic patterns. It involves sequential excision and immediate microscopic examination of margins until the tumor is completely removed. Other options include standard surgical excision, electrodesiccation and curettage (for low-risk, superficial lesions), cryotherapy, and topical therapies like imiquimod or 5-fluorouracil for superficial cancers.

From an MCAT perspective, you should be able to:

• Link cause to effect: UV radiation -> pyrimidine dimer formation -> DNA repair mechanisms (nucleotide excision repair) -> failure leading to mutation -> oncogenesis.
• Compare and contrast: Create a mental table contrasting BCC and SCC on origin cell, appearance, behavior (metastatic potential), and common genetic pathways.
• Apply foundational science: Understand how immunosuppression (a physiology/immunology topic) directly increases cancer risk by reducing cytotoxic T-cell and NK cell activity.

Common Pitfalls

1. Misdiagnosing aggressive subtypes: Mistaking a morpheaform BCC or a poorly differentiated SCC for a benign scar or inflammation can lead to delayed treatment and significant local destruction. Any persistent, non-healing lesion on sun-damaged skin must be biopsied.
2. Underestimating SCC metastasis risk: Thinking "skin cancer equals BCC equals harmless" is a dangerous oversimplification. Failing to recognize high-risk features in an SCC (e.g., depth, perineural invasion) can lead to inadequate initial treatment and poor follow-up, missing the window to treat metastatic disease.
3. Overlooking the role of immunosuppression: In clinical scenarios or exam questions, not immediately connecting a patient's transplant status or hematologic malignancy to a dramatically increased risk for aggressive, multiple SCCs is a critical oversight.
4. Inadequate patient counseling: Focusing on treatment without emphasizing strict, lifelong sun protection (broad-spectrum sunscreen, protective clothing, avoidance of peak sun) misses a key preventive opportunity, as these patients are at high risk for further skin cancers.

Summary

• Basal cell carcinoma (BCC) is the most common human cancer, typically appearing as a pearly papule with telangiectasias and rolled borders on sun-exposed skin. It is locally invasive but rarely metastasizes.
• Squamous cell carcinoma (SCC) arises from keratinocytes, often presenting as a scaly plaque or ulcerated nodule, and carries a significant potential for metastasis, especially in high-risk settings.
• Cumulative UV radiation exposure is the primary etiologic factor for both cancers, with immunosuppression being a major additional risk factor that particularly heightens the aggressiveness and frequency of SCC.
• Diagnosis is clinical but confirmed by biopsy; histology reveals distinct patterns (palisading in BCC, keratin pearls in SCC).
• Management prioritizes complete surgical excision, with Mohs surgery often used for cosmetically sensitive or high-risk areas. Patient education on sun protection is a cornerstone of long-term care.